Apomorphine
Back to searchMolecule Structure
Scientific Name
Apomorphine
Description of the Drug
Apomorphine is a morphine derivative D2 dopamine agonist used to treat hypomobile “off” episodes of advanced Parkinson’s disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00714
http://www.drugbank.ca/drugs/DB00714
Brand Name(s)
Not Available
Company Owner(s)
Sage Chemicals Inc, Mdd Us Operations Llc, Sunovion Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
D2-like dopamine receptor | PROTEIN FAMILY | AGONIST | CHEMBL2331075 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL8541 | ||
PharmGKB | PA164781163 | ||
Human Metabolome Database | HMDB0014852 | ||
DrugBank | DB00714 | ||
PubChem: Thomson Pharma | 14823961 | 14848260 | |
PubChem | 6005 | ||
Mcule | MCULE-3200317958 | ||
LINCS | LSM-25611 | ||
Nikkaji | J4.588H | ||
PDBe | OR9 | ||
BindingDB | 29644 | 50001955 | |
EPA CompTox Dashboard | DTXSID8022614 | ||
DrugCentral | 228 | ||
Metabolights | MTBLC48538 | ||
Brenda | 204689 | 13241 | |
Guide to Pharmacology | 33 | ||
rxnorm | APOMORPHINE | APOKYN | APOMORPHINE HYDROCHLORIDE |
ChEBI | 48538 | ||
ZINC | ZINC000000009073 |